Brown & Brown, Inc. (BRO) Stock Price & Analysis
Brown & Brown, Inc. (BRO) closed at USD 74.49 on Thursday, October 22, 2026, up 5.61% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 70.53; the Oct 22, 2026 session ranged USD 71.21–74.51 on volume of 2,480,248 shares. Market capitalization is $24.93B, with a 52-week range of USD 53.81–90.46 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:27 UTC.
Also available as compact Markdown for AI agents: nexqual.com/BRO.md
Key facts (BRO)
- Last four reported quarters (through Jun 30, 2026): revenue $6.79B, net income $1.21B (17.7% margin), free cash flow $1.45B (SEC filings).
- Valuation: P/E 20.7x (avg 25.3x at the last 3 fiscal year-ends).
- 3 of 80 tracked superinvestors hold BRO (13F, Q2 2026): 0 new, 1 added, 1 reduced, 1 unchanged.
- Analysts: Hold (mean 2.57 on a 1–5 scale) (21 analysts), mean target USD 74.67 (range 55–90).
- Total return with dividends: 1Y -15.3% vs S&P 500 +14.9%; 5Y +16.1% vs S&P 500 +80.3%.
- Next earnings: 2026-10-26, EPS estimate USD 1.08, revenue estimate $1.76B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (BRO)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $3.05B | $3.57B | $4.26B | $4.80B | $5.90B | $6.79B |
| Net income | $587M | $672M | $871M | $993M | $1.05B | $1.21B |
| EPS (diluted) | $2.07 | $2.37 | $3.05 | $3.46 | $3.16 | — |
| Free cash flow | $764M | $829M | $941M | $1.09B | $1.38B | $1.45B |
| Net margin | 19.2% | 18.8% | 20.5% | 20.7% | 17.9% | 17.7% |
| Revenue growth | +16.8% | +17.1% | +19.1% | +12.9% | +22.8% | — |
| Cash + short-term investments | $706M | $662M | $711M | $685M | — | — |
| Total debt | $2.02B | $3.94B | $3.80B | $3.82B | $7.61B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (BRO)
P/E 20.7x · P/S 3.7x · P/FCF 17.2x · P/B 2.0x · FCF yield 5.80% · Earnings yield 4.83% · Dividend yield (paid, TTM) 0.88%
P/E at fiscal year-ends: Dec 2025 23.7x, Dec 2024 29.2x, Dec 2023 22.9x.
Superinvestors (SEC 13F-HR, Q2 2026) (BRO)
3 of 80 tracked investors hold BRO. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Francois Rochon | Giverny Capital | 1.62% | $48.3M | Reduced -0.3% |
| First Eagle Investment | First Eagle Investment Management | 1.26% | $752M | Added +32.9% |
| Thomas Gayner | Markel Group | 0.01% | $898K | Unchanged |
Analysts (BRO)
Consensus Hold (mean 2.57 on a 1–5 scale), 21 analysts; mean target USD 74.67 (low 55, high 90).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-12 | Wells Fargo | Target lowered | Equal-Weight | $69 → $68 |
| 2026-10-12 | TD Cowen | Initiated | Buy | $82 |
| 2026-10-12 | Citizens | Target lowered | Market Outperform | $78 → $75 |
| 2026-10-07 | Mizuho | Target lowered | Outperform | $83 → $78 |
| 2026-10-07 | Barclays | Target lowered | Equal-Weight | $76 → $71 |
| 2026-10-06 | Morgan Stanley | Target lowered | Underweight | $60 → $55 |
| 2026-10-01 | JP Morgan | Target raised | Neutral | $80 → $83 |
| 2026-09-16 | Mizuho | Target lowered | Outperform | $86 → $83 |
| 2026-08-19 | Morgan Stanley | Target raised | Underweight | $56 → $60 |
| 2026-08-03 | JP Morgan | Target raised | Neutral | $78 → $80 |
| 2026-07-29 | Mizuho | Target raised | Outperform | $81 → $86 |
| 2026-07-29 | BMO Capital | Target raised | Market Perform | $73 → $74 |
Total return (dividends reinvested) (BRO)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | -15.3% | +16.1% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | -15.3% | +3.0% |
| Volatility (annualized) | 32.0% | 26.0% |
| Max drawdown | -38.3% (Oct 2025→May 2026) | -53.8% (Mar 2025→May 2026) |
BRO analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $1.08 | $1.07 | +0.9% | $1.76B | 20 |
| Next quarter (ends Dec 2026) | $0.94 | $0.92 | +2.1% | $1.65B | 20 |
| Current fiscal year (ends Dec 2026) | $4.48 | $4.48 | -0.0% | $6.99B | 21 |
| Next fiscal year (ends Dec 2027) | $4.83 | $4.84 | -0.1% | $7.29B | 21 |
Key Statistics (as of October 23, 2026 at 09:27 UTC)
| Price | USD 74.49 |
|---|---|
| Change | ▲ 5.61% (up) |
| Previous Close | USD 70.53 |
| Open | USD 71.47 |
| Day Range | USD 71.21 – 74.51 |
| 52-Week Range | USD 53.81 – 90.46 |
| Volume | 2,480,248 shares |
| Market Cap | $24.93B |
| Exchange | NYQ |
Technical Analysis (BRO)
Nexqual's technical model rates BRO "BUY" based on 5 bullish and 3 bearish signals across 127 daily candles, as of October 23, 2026 at 09:27 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 71.72 (overbought) |
| vs SMA50 | Above (USD 67.19) |
| MACD | 1.61 (positive) |
Analyst Ratings (BRO)
Wall Street analysts rate BRO "Hold" based on 21 analysts, with a mean price target of USD 74.67 (range USD 55–90), per Nexqual as of October 23, 2026 at 09:27 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 21 |
| Mean Target | USD 74.67 |
| High Target | USD 90 |
| Low Target | USD 55 |
| Buy / Hold / Sell | 7 / 13 / 1 |
Earnings (BRO)
| Next Earnings Date | 2026-10-26 |
|---|---|
| EPS Estimate | USD 1.08 |
| Revenue Estimate | $1.76B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 1.07 vs est 1.07 ▼ miss |
| 2026-03-31 | USD 1.39 vs est 1.36 ▲ beat |
| 2025-12-31 | USD 0.93 vs est 0.9 ▲ beat |
| 2025-09-30 | USD 1.05 vs est 0.93 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Financials & Fundamentals (BRO)
| Total Revenue | $6.66B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +32.40% |
| Gross Margin | +56.28% |
| Operating Margin | +41.84% |
| Profit Margin | +18.08% |
| ROE | +10.02% |
| Debt / Equity | 0.64 |
| Current Ratio | 1.13 |
| Total Cash | $918.00M |
| Total Debt | $8.07B |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $1.45B (21.3% of revenue) |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Financial Health Score (BRO)
Nexqual rates Brown & Brown, Inc.'s overall financial health "Solid" across five dimensions, as of October 23, 2026 at 09:27 UTC.
| Growth | Strong — Revenue +23% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 56%, operating 42% (last 12 months) |
| Balance Sheet | Solid — $918M cash vs $8.07B debt |
| Cash Flow | Strong — FCF $1.45B (last 4 quarters to Jun 2026, SEC), 21% margin |
| Efficiency | Mixed — ROE 10%, ROA 5.4% |
Ownership (BRO)
| Insider Ownership | +13.28% |
|---|---|
| Institutional Ownership | +86.31% |
| Shares Outstanding | 334.61M |
| Float | 287.56M |
| Short % of Float | +5.60% |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Leadership (BRO)
Brown & Brown, Inc. is led by J. Powell Brown C.P.C.U., CEO, President & Director, per Nexqual as of October 23, 2026 at 09:27 UTC.
| CEO, President & Director | J. Powell Brown C.P.C.U. |
|---|---|
| Executive VP & CFO | R. Andrew Watts |
| President of Retail Segment, Executive VP & COO | Stephen Patrick Hearn |
| Executive VP & Chairman of Specialty Distribution Segment | Chris L. Walker |
| Chief Technology Officer | Kiet Tran |
Major Backers & Investors (BRO)
Notable institutional backers of Brown & Brown, Inc. include FMR, LLC, Principal Financial Group, Inc., Capital Group, according to Nexqual as of October 23, 2026 at 09:27 UTC.
Active Investors
| Investor | Stake |
|---|---|
| FMR, LLC | 5.5% |
| Principal Financial Group, Inc. | 4.7% |
| Capital Group | 4.32% |
| First Eagle Investment Management, LLC | 3.5% |
| Principal Funds, Inc-MidCap Fund | 3.07% |
| AMERICAN BALANCED FUND | 2.31% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 10.03% |
| BlackRock | 6.61% |
| State Street | 4.34% |
| Geode Capital | 2.46% |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| WTW | Willis Towers Watson Public Lim | USD 332.18 | ▲ 4.58% |
| ERIE | Erie Indemnity Company | USD 256.8 | ▲ 5.19% |
| RYAN | Ryan Specialty Holdings, Inc. | USD 44.49 | ▲ 5.28% |
| AON | Aon plc | USD 306.8 | ▲ 4.23% |
| AJG | Arthur J. Gallagher & Co. | USD 270.98 | ▲ 4.88% |
| MRSH | Marsh | USD 199.27 | ▲ 4.57% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:27 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt